All News
Filter News
Found 2,990 articles
-
Roche to Invest $200 Million for New Research Center, Creating 200 Jobs
8/19/2011
-
Adherex Technologies Inc. Reports Recent Developments and Second Quarter June 30, 2011 Financial Results
8/12/2011
-
Ironwood Pharmaceuticals's 2Q Loss Widens as Expenses Grow
8/11/2011
-
Sunshine Biopharma, Inc. Looking to Mimic Roche's Billion Dollar Cancer Drug Success
8/2/2011
-
Vertex Pharmaceuticals (MA) Release: Four Hep C Drugs Better Than Three
7/28/2011
-
PDL BioPharma, Inc. Announces Second Quarter 2011 Financial Results
7/28/2011
-
Merck & Co., Inc. and Roche Expand Agreement in Fight Against Chronic Hepatitis C
7/20/2011
-
DVS Sciences Raises $14.6 Million in Series A Financing to Advance Commercialization of Novel Single-Cell Analysis Technology
7/14/2011
-
BioInvent Interim Report 1 January - 30 June 2011
7/14/2011
-
Baxter International, Inc. and Halozyme Therapeutics, Inc. Announce Top-Line Results of Phase III Study of HyQ in Patients with Primary Immunodeficiency
7/8/2011
-
Oncolytics Biotech Inc. Announces Appointment of Dr. George M. Gill as Chief Medical Officer
7/6/2011
-
Ernst & Young LLP Despite Renewed Growth in 2010, Biotech Industry Faces R&D Challenges
6/14/2011
-
Merck & Co., Inc., Roche Pair Up on Tests for Cancer Treatments
6/7/2011
-
Kendle International Appoints Pierre Geoffroy, MD, CM, MSc, FCFP Vice President, Early Stage
6/7/2011
-
FDA Approves Vertex Pharmaceuticals (MA)'s INCIVEK(TM) (telaprevir) for People with Hepatitis C
5/24/2011
-
Roche Symposium Showcases Accomplishments of Next Generation of Chemists
5/23/2011
-
Rivals Merck & Co., Inc., Roche Team Up on Hepatitis C Drugs, Raising Ante in Vertex Pharmaceuticals (MA) Rivalry
5/17/2011
-
Roche Diagnostics Corporation Launches the Cobas(R) 8000 Modular Analyzer Series in Canada at BC Biomedical Laboratories
5/12/2011
-
Response Biomedical Enters Into Exclusive Canadian Distribution Agreement with Fisher Scientific Company
5/4/2011
-
FDA Advisory Committee Unanimously Recommends Approval of Vertex Pharmaceuticals (MA)'s Telaprevir for People with Hepatitis C
4/29/2011